718 related articles for article (PubMed ID: 30584302)
1. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
[TBL] [Abstract][Full Text] [Related]
2. Bovine Serum Albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug.
Nosrati H; Sefidi N; Sharafi A; Danafar H; Kheiri Manjili H
Bioorg Chem; 2018 Feb; 76():501-509. PubMed ID: 29310081
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Intestinal Absorption Mechanism and Pharmacokinetics of Curcumin-Loaded Galactosylated Albumin Nanoparticles.
Huang Y; Deng S; Luo X; Liu Y; Xu W; Pan J; Wang M; Xia Z
Int J Nanomedicine; 2019; 14():9721-9730. PubMed ID: 31849464
[TBL] [Abstract][Full Text] [Related]
4. Production of biological nanoparticles from bovine serum albumin as controlled release carrier for curcumin delivery.
Salehiabar M; Nosrati H; Javani E; Aliakbarzadeh F; Kheiri Manjili H; Davaran S; Danafar H
Int J Biol Macromol; 2018 Aug; 115():83-89. PubMed ID: 29653171
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
6. Development of curcumin-loaded galactosylated chitosan-coated nanoparticles for targeted delivery of hepatocellular carcinoma.
Huang M; Liu J; Fan Y; Sun J; Cheng JX; Zhang XF; Zhai BT; Guo DY
Int J Biol Macromol; 2023 Dec; 253(Pt 6):127219. PubMed ID: 37802456
[TBL] [Abstract][Full Text] [Related]
7.
Sun R; Fang L; Lv X; Fang J; Wang Y; Chen D; Wang L; Chen J; Qi Y; Tang Z; Zhang J; Tian Y
Drug Deliv; 2021 Dec; 28(1):2071-2084. PubMed ID: 34595970
[TBL] [Abstract][Full Text] [Related]
8. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.
Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y
Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
[TBL] [Abstract][Full Text] [Related]
10. BSA Nanoparticles Modified with
Zhang S; Asghar S; Yu F; Chen Z; Hu Z; Ping Q; Shao F; Xiao Y
J Agric Food Chem; 2019 Aug; 67(33):9371-9381. PubMed ID: 31379162
[TBL] [Abstract][Full Text] [Related]
11. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.
Hong W; Guo F; Yu N; Ying S; Lou B; Wu J; Gao Y; Ji X; Wang H; Li A; Wang G; Yang G
Drug Des Devel Ther; 2021; 15():2843-2855. PubMed ID: 34234415
[TBL] [Abstract][Full Text] [Related]
12. Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer.
Zhao X; Chen Q; Liu W; Li Y; Tang H; Liu X; Yang X
Int J Nanomedicine; 2015; 10():257-70. PubMed ID: 25565818
[TBL] [Abstract][Full Text] [Related]
13. Galactosylated alginate-curcumin micelles for enhanced delivery of curcumin to hepatocytes.
Sarika PR; James NR; Kumar PR; Raj DK
Int J Biol Macromol; 2016 May; 86():1-9. PubMed ID: 26774374
[TBL] [Abstract][Full Text] [Related]
14. Lactosylated Albumin Nanoparticles: Potential Drug Nanovehicles with Selective Targeting Toward an In Vitro Model of Hepatocellular Carcinoma.
Teran-Saavedra NG; Sarabia-Sainz JA; Silva-Campa E; Burgara-Estrella AJ; Guzmán-Partida AM; Ramos-Clamont Montfort G; Pedroza-Montero M; Vazquez-Moreno L
Molecules; 2019 Apr; 24(7):. PubMed ID: 30970533
[TBL] [Abstract][Full Text] [Related]
15. Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles.
Bian Y; Guo D
Drug Des Devel Ther; 2020; 14():647-659. PubMed ID: 32109990
[TBL] [Abstract][Full Text] [Related]
16. Galactosylated chitosan-polycaprolactone nanoparticles for hepatocyte-targeted delivery of curcumin.
Zhou N; Zan X; Wang Z; Wu H; Yin D; Liao C; Wan Y
Carbohydr Polym; 2013 Apr; 94(1):420-9. PubMed ID: 23544558
[TBL] [Abstract][Full Text] [Related]
17. Curcumin-Loaded Hybrid Nanoparticles: Microchannel-Based Preparation and Antitumor Activity in a Mouse Model.
Hong W; Gao Y; Lou B; Ying S; Wu W; Ji X; Yu N; Jiao Y; Wang H; Zhou X; Li A; Guo F; Yang G
Int J Nanomedicine; 2021; 16():4147-4159. PubMed ID: 34168445
[TBL] [Abstract][Full Text] [Related]
18. Functionalizing the surface of hydroxyapatite drug carrier with carboxylic acid groups to modulate the loading and release of curcumin nanoparticles.
Lee WH; Loo CY; Rohanizadeh R
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():929-939. PubMed ID: 30889767
[TBL] [Abstract][Full Text] [Related]
19. Poly(lactic-
Kumar P; Singh AK; Raj V; Rai A; Keshari AK; Kumar D; Maity B; Prakash A; Maiti S; Saha S
Int J Nanomedicine; 2018; 13():975-990. PubMed ID: 29497292
[TBL] [Abstract][Full Text] [Related]
20. Folic acid conjugated bovine serum albumin: An efficient smart and tumor targeted biomacromolecule for inhibition folate receptor positive cancer cells.
Nosrati H; Abbasi R; Charmi J; Rakhshbahar A; Aliakbarzadeh F; Danafar H; Davaran S
Int J Biol Macromol; 2018 Oct; 117():1125-1132. PubMed ID: 29885392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
